Trials / Completed
CompletedNCT00960882
Gastric Tolerability and Pharmacokinetics of DMMET-01
Gastric Tolerability and Pharmacokinetics of DMMET-01. Daily Intake for 30 Days, in Normal Alimentation Conditions, in Healthy Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Laboratorios Silanes S.A. de C.V. · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of a new drug for the treatment of type 2 diabetes, DMMET-01, in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMMET-01 | 1050.6 mg daily for 30 days |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2008-03-01
- Completion
- 2008-04-01
- First posted
- 2009-08-18
- Last updated
- 2018-01-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00960882. Inclusion in this directory is not an endorsement.